JENSCARE-B(09877): Ken-Valve has been approved by the Hong Kong Department of Health.

JENSCARE-B (09877) has announced that the company's transcatheter aortic valve system Ken-Valve has recently received approval from the Hong Kong Department of Health (Hong Kong Health Department), and the company is actively promoting the commercialization of the product in Hong Kong. Thanks to the product's differentiated advantages, ongoing therapy promotion efforts, and extensive commercial application experience, Ken-Valve has gained wide market acceptance. The approval of Ken-Valve by the Hong Kong Health Department further confirms the potential of the product in the treatment of aortic valve regurgitation (or combined stenosis). The company will continue to accelerate the global commercialization process of Ken-Valve comprehensively in order to further achieve the company's long-term strategic goals.